On July 23-24, 2026 , the FDA's Pharmacy Compounding Advisory Committee (PCAC) will convene at the FDA White Oak Campus (10903 New Hampshire Avenue, Silver Spring, MD 20993) to evaluate whether several peptides should be added to the Section 503A bulk drug substances list
Use a Reconstitution Peptide Calculator to determine the exact dosage
Promotes rapid healing of muscle tears, wounds, and surgical sites through enhanced blood flow and cellular regeneration processes
It has also been studied with respect to fibroblast migration and blood vessel formation
BPC 157 mitigates damaging effects, preserving neuronal structures and promoting nerve cell regeneration
mTOR, mammalian target of rapamycinMammalian target of rapamycin